FSA
IMDX
Fort Sheridan Advisors’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-135,000
| Closed | -$99K | – | 187 |
|
|
2022
Q3 | $99K | Hold |
135,000
| – | – | 0.03% | 176 |
|
|
2022
Q2 | $121K | Hold |
135,000
| – | – | 0.04% | 174 |
|
|
2022
Q1 | $201K | Hold |
135,000
| – | – | 0.06% | 173 |
|
|
2021
Q4 | $293K | Buy |
135,000
+25,000
| +23% | +$54.3K | 0.08% | 155 |
|
|
2021
Q3 | $392K | Buy |
110,000
+1,000
| +0.9% | +$3.56K | 0.13% | 119 |
|
|
2021
Q2 | $626K | Buy |
109,000
+6,000
| +6% | +$34.5K | 0.21% | 86 |
|
|
2021
Q1 | $535K | Buy |
+103,000
| New | +$535K | 0.21% | 75 |
|